Synovial tissue heterogeneity and peripheral blood biomarkers

Current Rheumatology Reports

Volumn 13, Issue 5, 2011, Pages 440-448

  Bugatti, Serena ^a   Manzo, Antonio ^a   Bombardieri, Michele ^b   Vitolo, Barbara ^a   Humby, Frances ^b   Kelly, Stephen ^b   Montecucco, Carlomaurizio ^a   Pitzalis, Costantino ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Biomarker; Heterogeneity; Peripheral blood; Rheumatoid arthritis; Synovial membrane; Synovial tissue

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BIOTECHNOLOGY; BLOOD; CELL INFILTRATION; CELL INTERACTION; CELL POPULATION; CLINICAL RESEARCH; DISEASE COURSE; DISEASE MARKER; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; NON INVASIVE PROCEDURE; PATHOGENESIS; RHEUMATOID ARTHRITIS; SYNOVIUM;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; SYNOVIAL MEMBRANE;

EID: 80755172249     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0201-y     Document Type: Article

References (69)

1. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-8. (Pubitemid 34539104)
2. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241-50. (Pubitemid 38140764)
3. Haldorsen K, Moen K, Jacobsen H, Jonsson R, Brun JG. Exocrine function in primary Sjögren syndrome: natural course and prognostic factors. Ann Rheum Dis. 2008;67:949-54. (Pubitemid 351956656)
4. Austin HA, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: importance of race and clinical and histologic factors in 166 patients. Nephrol Dial Transplant. 1995;10:1620-8.
5. Mittal B, Rennke H, Singh AK. The role of kidney biopsy in the management of lupus nephritis. Curr Opin Nephrol Hypertens. 2005;14:1-8. (Pubitemid 40110693)
6. Baeten D, Demetter P, Cuvelier C, et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis. 2000;59:945-53.
7. van de Sande MG, Thurlings RM, Boumans MJ, et al. Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome: is it a constant feature over time? Ann Rheum Dis. 2010. doi:10.1136/ard.2010.139287.
8. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996;39:115-24. (Pubitemid 26036386)
9. Kraan MC, Haringman JJ, Weedon H, et al. Tcells, fibroblast-like synoviocytes, and granzyme B+cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis. Ann Rheum Dis. 2004;63:483-8. (Pubitemid 38530189)
10. Tak PP, Taylor PC, Breedveld FC, Smeets TJ, Daha MR, Kluin PM, et al. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:1077-81. (Pubitemid 26240218)
11. Barrera P, Joosten LA, den Broeder AA, van de Putte LB, van Riel PL, van den Berg WB. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis. Ann Rheum Dis. 2001;60:660-9. (Pubitemid 32588369)
12. Thurlings RM, Vos K, Wijbrandts CA, Zwinderman AH, Gerlag DM, Tak PP. Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. Ann Rheum Dis. 2008;67:917-25. (Pubitemid 351956651)
13. Kavanaugh A, Rosengren S, Lee SJ, et al. Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. Ann Rheum Dis. 2008;67:402-8. (Pubitemid 351281278)
14. Manzo A, Bombardieri M, Humby F, Pitzalis C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. Immunol Rev. 2010;233:267-85.
15. Schett G, Firestein GS. Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2010;69:787-9.
16. van de Sande MG, Gerlag DM, Lodde BM, et al. Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials. Ann Rheum Dis. 2011;70:423-7.
17. Kraan MC, Reece RJ, Smeets TJ, Veale DJ, Emery P, Tak PP Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: implications for pathogenesis and evaluation of treatment. Arthritis Rheum. 2002;46:2034-8.
18. Scirè CA, Epis O, Codullo V, et al. Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure. Arthritis Res Ther. 2007, 9:R101.
19. Kraan MC, Versendaal H, Jonker M, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 1998;41:1481-8. (Pubitemid 28373129)
20. • van de Sande MG, de Hair MJ, van der Leij C, et al: Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 2010, doi:10.1136/ard.2010.139527. This work is the first to investigate the pathological features of the synovial membrane in nonarthritic individuals at risk of developing RA. Availability of synovial tissue from unaffected joints is allowed by mini-invasive small-bore arthroscopy of the knee.
21. Rooney T, Bresnihan B, Andersson U, et al. Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis. Ann Rheum Dis. 2007;66:1656-60. (Pubitemid 350205457)
22. van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, et al. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun. 2003;4:187-96. (Pubitemid 38967596)
23. Lindberg J, af Klint E, Ulfgren AK, et al. Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology. Arthritis Res Ther. 2006, 8:R47.
24. Tak PP, Smeets TJ, Daha MR, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 1997;40:217-25. (Pubitemid 27114085)
25. Tsubaki T, Arita N, Kawakami T, et al. Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens. Arthritis Res Ther. 2005, 7:R825-836.
26. van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum. 2008;58:53-60.
27. Baeten D, Kruithof E, De Rycke L, et al. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy. Arthritis Res Ther. 2005, 7:R359-369.
28. Haringman JJ, Gerlag DM, Zwinderman AH, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64:834-8. (Pubitemid 40733904)
29. Wijbrandts CA, Vergunst CE, Haringman JJ, Gerlag DM, Smeets TJ, Tak PP. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum. 2007;56:3869-71. (Pubitemid 350100720)
30. Baeten D, Houbiers J, Kruithof E, et al. Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis. Ann Rheum Dis. 2006;65:990-7. (Pubitemid 44133259)
31. David JP, Schett G. TNF and bone. Curr Dir Autoimmun. 2010;11:135-44.
32. Danks L, Sabokbar A, Gundle R, Athanasou NA. Synovial macrophage-osteoclast differentiation in inflammatory arthritis. Ann Rheum Dis. 2002;61:916-21.
33. Kasperkovitz PV, Timmer TC, Smeets TJ, et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and highinflammation synovitis. Arthritis Rheum. 2005;52:430-41. (Pubitemid 40216307)
34. Bauer S, Jendro MC, Wadle A, et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther. 2006, 8:R171.
35. Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE, Huizinga TW. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 2005;52:1999-2002. (Pubitemid 40994321)
36. Holt AP, Haughton EL, lalor PF, Filer A, Buckley CD, Adams DH. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology. 2009;136:705-14.
37. Manzo A, Bugatti S, Caporali R, et al. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am J Pathol. 2007;171:1549-62. (Pubitemid 350158316)
38. Bradfield PF, Amft N, Vernon-Wilson E, et al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum. 2003;48:2472-82. (Pubitemid 37129424)
39. Timmer TC, Baltus B, Vondenhoff M, et al. Inflammation and ectopic lymphoid strucutes in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum. 2007;56:2492-502. (Pubitemid 47237268)
40. Flavell SJ, Hou TZ, Lax S, Filer AD, Salmon M, Buckley CD. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol. 2008;153(1):S241-6. (Pubitemid 351340977)
41. Takemura S, Braun A, Crowson C, et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol. 2001;167:1072-80. (Pubitemid 32660867)
42. Manzo A, Paoletti S, Carulli M, et al. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol. 2005;35:1347-59. (Pubitemid 40691416)
43. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J Immunol. 2001;167:4710-8. (Pubitemid 32954353)
44. Yanni G, Whelan A, Feighery C, et al. Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration. Clin Exp Immunol. 1993;93:387-95. (Pubitemid 23276265)
45. Klimiuk PA, Goronzy JJ, Björnsson J, Beckenbaugh RD, Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol. 1997;151:1311-9. (Pubitemid 27479761)
46. Bugatti S, Manzo A, Vitolo B, et al. Clinical, radiographic and biomolecular features of B cell synovitis in rheumatoid arthritis. Arthritis Rheum. 2010, 62:S260 [abstract].
47. •• Humby F, Bombardieri M, Manzo A, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009;6:e1. The authors took advantage of a combined in vivo and ex vivo approach to demonstrate the functionality of synovial B-cell follicles in RA. They showed that B cells in the context of large lymphoid aggregates express AID, the key enzyme required for somatic hypermutation and class-switch recombination of the immunoglobulin genes, and support the production of ACPA antibodies when xenotransplanted into SCID mice.
48. •• Scheel T, Gursche A, zacher J, Häupl T, Berek C. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion with accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum. 2011;63:63-72. This work aimed to identify the clonality of B cells and plasma cells within RA synovial tissues. Through laser capture microdissection of B cells and plasma cells and Ig VH gene sequencing, the authors elegantly demonstrated that plasma cells are clonally related to B cells, thus providing evidence of the local differentiation of B cells.
49. Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, Tak PP. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology. 1999;38:1074-80. (Pubitemid 29537326)
50. Klimiuk PA, Sierakowski S, Latosiewicz R, et al. Circulating tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with different patterns of rheumatoid synovitis. Ann Rheum Dis. 2003;62:472-5. (Pubitemid 36469742)
51. Thurlings RM, Wijbrandts CA, Mebius RE, et al. Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. Arthritis Rheum. 2008;58:1582-9. (Pubitemid 351847511)
52. Canete JD, Celis R, Moll C, et al. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis. 2009;68:751-6.
53. Klaasen R, Thurlings RM, Wijbrandts CA, et al. The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study. Arthritis Rheum. 2009;60:3217-4.
54. Magliozzi R, Howell OW, Reeves C, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol. 2010;68:477-93.
55. Walsh NC, Gravallese EM. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev. 2010;233:301-12.
56. Crotti TN, Smith MD, Weedon H, et al. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis. 2002;61:1047-54. (Pubitemid 35397349)
57. Haynes DR, Barg E, Crotti TN, et al. Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology. 2003;42:123-34. (Pubitemid 36131578)
58. Thaunat O, Patey N, Caligiuri G, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol. 2010;185:717-28.
59. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP Zendman AJ, Eklund A, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67:1488-92.
60. Klareskog L, Malmström V, Lundberg K, Padyukov L, Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol. 2011. doi:10.1016/j.smim.2011.01.014.
61. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380-6. (Pubitemid 38198821)
62. Rooney T, Roux-Lombard P, Veale DJ, FitzGerald O, Dayer JM, Bresnihan B. Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade. Ann Rheum Dis. 2010;69:706-14.
63. •• van Baarsen LG, Wijbrandts CA, Timmer TC, van der Pouw Kraan TC, Tak PP, Verweij CL. Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood. Arthritis Rheum. 2010;62:1602-7. This important work opens the avenue for comparative synovialperipheral blood profiling in RA. The authors analyzed extensive gene expression of paired synovial tissue biopsies and whole peripheral blood using complementary DNA microarrays. Although the work failed to highlight significant overlap, it provides the rationale for further studies focused on specific peripheral blood cell populations or molecular pathways.
64. McKinney EF, Lyons PA, Carr EJ, Hollis JL, Jayne DR, Willcocks LC, et al. A CD8+ Tcell transcription signature predicts prognosis in autoimmune disease. Nat Med. 2010;16:586-91.
65. Manzo A, Vitolo B, Humby F, et al. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum. 2008;58:3377-87.
66. Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, et al. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Arthritis Rheum. 2008;58:2257-67.
67. Mao Y, Wang M, Zhou Q, et al. CXCL10 and CXCL13 expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy. J Clin Immunol. 2010. doi:10.1007/s10875- 010-9500-8.
68. Mao YY, Yang H, Wang M, et al. Feasibility of diagnosing renal allograft dysfunction by oligonucleotide array: gene expression profile correlates with histopathology. Transpl Immunol. 2011;24:172-80.
69. Rosengren S, Wei N, Kalunian KC, Kavanaugh A, Boyle DL. CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis. Rheumatology. 2011;50:603-10.